These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 2973984
1. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160. Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D. Eur J Biochem; 1988 Nov 15; 177(3):575-82. PubMed ID: 2973984 [Abstract] [Full Text] [Related]
2. Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158. Nelles L, Lijnen HR, Collen D, Holmes WE. J Biol Chem; 1987 Apr 25; 262(12):5682-9. PubMed ID: 3106341 [Abstract] [Full Text] [Related]
3. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu). Lijnen HR, Van Hoef B, Nelles L, Collen D. J Biol Chem; 1990 Mar 25; 265(9):5232-6. PubMed ID: 1969415 [Abstract] [Full Text] [Related]
4. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala. Lijnen HR, Li XK, Nelles L, Hu MH, Collen D. Eur J Biochem; 1992 Apr 15; 205(2):701-9. PubMed ID: 1533368 [Abstract] [Full Text] [Related]
5. Enzymatic properties of single-chain and two-chain forms of a Lys158----Glu158 mutant of urokinase-type plasminogen activator. Lijnen HR, Van Hoef B, Nelles L, Holmes WE, Collen D. Eur J Biochem; 1988 Feb 15; 172(1):185-8. PubMed ID: 2894309 [Abstract] [Full Text] [Related]
10. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158). Gurewich V, Pannell R, Broeze RJ, Mao J. J Clin Invest; 1988 Dec 15; 82(6):1956-62. PubMed ID: 2974047 [Abstract] [Full Text] [Related]
13. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin. Dewerchin M, Lijnen HR, Van Hoef B, De Cock F, Collen D. Eur J Biochem; 1989 Oct 20; 185(1):141-9. PubMed ID: 2530085 [Abstract] [Full Text] [Related]
14. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis. Fleury V, Lijnen HR, Anglés-Cano E. J Biol Chem; 1993 Sep 05; 268(25):18554-9. PubMed ID: 8103046 [Abstract] [Full Text] [Related]
16. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N. Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727 [Abstract] [Full Text] [Related]
18. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator. Ueshima S, Holvoet P, Lijnen HR, Nelles L, Seghers V, Collen D. Thromb Haemost; 1994 Jan 03; 71(1):134-40. PubMed ID: 8165632 [Abstract] [Full Text] [Related]
19. Characterization of thrombin- and plasmin-resistant mutants of recombinant human single chain urokinase-type plasminogen activator. Eguchi Y, Sakata Y, Matsuda M, Osada H, Numao N, Ohmori M, Kondo K. J Biochem; 1990 Jul 03; 108(1):72-9. PubMed ID: 2146258 [Abstract] [Full Text] [Related]